Improvement in immune dysfunction after FOLFOX chemotherapy for stage III colon cancer is associated with improved minimal residual disease prognostic subtype and outcome

2021 ◽  
Author(s):  
Nigel P Murray ◽  
Ricardo Villalon ◽  
Dan Hartmann ◽  
Maria Patricia Rodriguez ◽  
Socrates Aedo
2019 ◽  
Vol 13 ◽  
Author(s):  
Nigel P Murray ◽  
Sócrates Aedo ◽  
Ricardo Villalon ◽  
Marco Antonio Lopez ◽  
Simona Minzer ◽  
...  

2015 ◽  
Vol 4 (4) ◽  
pp. 157-166 ◽  
Author(s):  
Paul H Sugarbaker ◽  
Paolo Sammartino ◽  
Antonios-Apostolos Tentes

2016 ◽  
Vol 8 (346) ◽  
pp. 346ra92-346ra92 ◽  
Author(s):  
Jeanne Tie ◽  
Yuxuan Wang ◽  
Cristian Tomasetti ◽  
Lu Li ◽  
Simeon Springer ◽  
...  

2015 ◽  
Vol 14 (4) ◽  
pp. 262-268.e1 ◽  
Author(s):  
Aalok Kumar ◽  
Renata D. Peixoto ◽  
Hagen F. Kennecke ◽  
Daniel J. Renouf ◽  
Howard J. Lim ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document